[
  {
    "date": "2023-12-30",
    "symbol": "CTMX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CTMX",
    "entityregistrantname": "CytomX Therapeutics, Inc.",
    "entitycentralindexkey": 1501989,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37587",
    "entitytaxidentificationnumber": "27-3521219",
    "entityaddressaddressline1": "151 Oyster Point Boulevard,",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "515-3185",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.00001 par value",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "San Jose, California",
    "documentfinstmterrorcorrectionflag": "true",
    "documentfinstmtrestatementrecoveryanalysisflag": "false",
    "cashandcashequivalentsatcarryingvalue": 17171000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 157338000,
    "accountsreceivablenetcurrent": 3432000,
    "prepaidexpenseandotherassetscurrent": 4995000,
    "assetscurrent": 182936000,
    "propertyplantandequipmentnet": 3958000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 729000,
    "goodwill": 949000,
    "restrictedcashnoncurrent": 917000,
    "operatingleaserightofuseasset": 12220000,
    "otherassetsnoncurrent": 83000,
    "assets": 201792000,
    "accountspayablecurrent": 1458000,
    "accruedliabilitiescurrent": 17599000,
    "operatingleaseliabilitycurrent": 4589000,
    "contractwithcustomerliabilitycurrent": 132267000,
    "liabilitiescurrent": 155913000,
    "contractwithcustomerliabilitynoncurrent": 80048000,
    "operatingleaseliabilitynoncurrent": 9385000,
    "otherliabilitiesnoncurrent": 3893000,
    "liabilities": 249239000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 675905000,
    "accumulatedothercomprehensiveincomelossnetoftax": 95000,
    "retainedearningsaccumulateddeficit": -723448000,
    "stockholdersequity": -47447000,
    "liabilitiesandstockholdersequity": 201792000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 67310838,
    "commonstocksharesoutstanding": 67310838,
    "revenuefromcontractwithcustomerexcludingassessedtax": 101214000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseAndServiceMember",
    "researchanddevelopmentexpense": 77680000,
    "generalandadministrativeexpense": 30018000,
    "operatingexpenses": 107698000,
    "operatingincomeloss": -6484000,
    "investmentincomeinterest": 9837000,
    "othernonoperatingincomeexpense": -30000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 3323000,
    "incometaxexpensebenefit": 3892000,
    "netincomeloss": -569000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 85000,
    "comprehensiveincomenetoftax": -484000,
    "incomelossfromcontinuingoperationsperbasicshare": -0.01,
    "incomelossfromcontinuingoperationsperdilutedshare": -0.01,
    "weightedaveragenumberofsharesoutstandingbasic": 73808237,
    "weightedaveragenumberofdilutedsharesoutstanding": 73808237,
    "sharesissued": 67310838,
    "stockissuedduringperiodsharesstockoptionsexercised": 16535,
    "stockissuedduringperiodvaluestockoptionsexercisedandrestrictedstockunitsreleased": 26000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexerciseofstockoptionsandreleaseofrestrictedstockunitsinperiod": 675864,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 535000,
    "issuanceprefundedwarrantsnetofissuancecost": 29669000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 406928,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8558000,
    "profitloss": -569000,
    "amortizationofintangibleassets": 146000,
    "depreciationandamortizationexcludingamortizationofintangibleassets": 2029000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 7419000,
    "sharebasedcompensation": 8558000,
    "noncashleaseexpense": -3729000,
    "increasedecreaseinaccountsreceivable": -32554000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2471000,
    "increasedecreaseinotheroperatingassets": 56000,
    "increasedecreaseinaccountspayable": -1426000,
    "increasedecreaseinaccruedandotherliabilitiesnoncurrent": -7041000,
    "increasedecreaseincontractwithcustomerliability": -89011000,
    "netcashprovidedbyusedinoperatingactivities": -56035000,
    "paymentstoacquirepropertyplantandequipment": 840000,
    "paymentstoacquireshortterminvestments": 424834000,
    "proceedsfromsalematurityandcollectionofshortterminvestments": 275000000,
    "netcashprovidedbyusedininvestingactivities": -150674000,
    "proceedsfromissuanceofwarrants": 29669000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 561000,
    "netcashprovidedbyusedinfinancingactivities": 30230000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -176479000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 18088000,
    "capitalexpendituresincurredbutnotyetpaid": 75000,
    "numberofbusinessactivities": 1,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 13805472,
    "weightedaveragenumberofsharesissuedbasic": 66655971,
    "weightedaveragenumberofsharescontingentlyissuable": 7152266,
    "cashcashequivalentsandshortterminvestments": 175364000,
    "cashcashequivalentsandshortterminvestmentsaccumulatedgrossunrealizedgainbeforetax": 95000,
    "restrictedcashandcashequivalentsatcarryingvalue": 917000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 157243000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 175269000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 95000,
    "availableforsalesecuritiesdebtsecurities": 157338000,
    "laboratoryequipmentgross": 14119000,
    "computerequipmentandsoftwaregross": 1125000,
    "furnitureandfixturesgross": 1051000,
    "leaseholdimprovementsgross": 1983000,
    "constructioninprogressgross": 368000,
    "propertyplantandequipmentgross": 18646000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 14688000,
    "depreciation": 2000000,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": "P12Y",
    "finitelivedintangibleassetsgross": 1750000,
    "finitelivedintangibleassetsaccumulatedamortization": 1021000,
    "finitelivedintangibleassetsnet": 729000,
    "accruedresearchandclinicalcurrent": 8435000,
    "employeerelatedliabilitiescurrent": 8160000,
    "accruedprofessionalfeescurrent": 690000,
    "otheraccruedliabilitiescurrent": 314000,
    "revenues": 3688000,
    "milestonepaymentreceived": 100000000,
    "aggregatecollaborationtransactionamount": 51700000,
    "estimatedresearchserviceperiod": "P4Y",
    "contractwithcustomerliability": 12800000,
    "contractwithcustomerassetnet": 2200000,
    "researchanddevelopmentarrangementcontracttoperformforothersdescriptionandterms": "Each collaboration target had a two-year research term and the two additional targets had to be nominated by Bristol Myers Squibb within five years of the effective date of the BMS Agreement. The research term for each collaboration target could be extended in one year increments up to three times.",
    "upfrontfeereceived": 30000000,
    "estimatedresearchfund": 21700000,
    "contractwithcustomerliabilityadditions": 6438000,
    "contractwithcustomerliabilityrevenuerecognized": -95449000,
    "deferredrevenuerecognitionmaturityyear": 2026,
    "royaltyobligationsfutureminimumpaymentsdue": 200000,
    "licenseterminationperiod": "P60D",
    "sublicensefees": 200000,
    "losscontingencynameofplaintiff": "Vytacera Bio, LLC",
    "lesseeoperatingleasedescription": "The 2016 Lease has an initial term of ten years through 2026 and the Company has an option to extend the initial term for an additional five years at the then fair rental value as determined pursuant to the 2016 Lease.",
    "lesseeoperatingleasetermofcontract": "P10Y",
    "lettersofcreditoutstandingamount": 900000,
    "operatingleaseexpense": 5100000,
    "subleaseincome": 900000,
    "operatingleasepayments": 5420000,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y9M",
    "operatingleaseweightedaveragediscountratepercent": 0.0825,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5572000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5729000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4387000,
    "lesseeoperatingleaseliabilitypaymentsdue": 15688000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1714000,
    "operatingleaseliability": 13974000,
    "lesseeoperatingleasesfutureminimumpaymentsduefutureminimumsubleaserentalsdueinnexttwelvemonths": 1333000,
    "lesseeoperatingleasesfutureminimumpaymentsduefutureminimumsubleaserentalsdueinyeartwo": 1379000,
    "lesseeoperatingleasesfutureminimumpaymentsduefutureminimumsubleaserentalsdueinyearthree": 1067000,
    "lesseeoperatingleasesfutureminimumpaymentsduefutureminimumsubleaserentals": 3779000,
    "warrantsandrightsoutstandingmaturitydate": "2043-07-31",
    "classofwarrantorrightoutstanding": 14423077,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.00001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardvotingrightsofcommonstockholdingpercentage": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.0208,
    "commonstockcapitalsharesreservedforfutureissuance": 2944245,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 5000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 8200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "allocatedsharebasedcompensationexpense": 2000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 724342,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 2171000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 12949612,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1938573,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2262264,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 8672013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 9.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y6M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y6M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 70500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 4700,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1400529,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 439329,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 97368,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P0Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y1M6D",
    "valuationallowancedeferredtaxassetchangeinamount": 9400000,
    "unrecognizedtaxbenefitsincometaxpenaltiesandinterestexpense": 3900000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 2300000,
    "operatinglosscarryforwards": 269700000,
    "operatinglosscarryforwardsexpirationyear": 2034,
    "operatinglosscarryforwardsamounttoexpireifnotused": 65600000,
    "operatinglosscarryforwardsamountnotsubjecttoexpiration": 204100000,
    "taxcreditcarryforwardamount": 24400000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "unrecognizedtaxbenefitsincometaxpenaltiesexpense": 1000000,
    "unrecognizedtaxbenefitsinterestonincometaxesexpense": 600000,
    "currentstateandlocaltaxexpensebenefit": 3892000,
    "currentincometaxexpensebenefit": 3892000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -4.787,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.472,
    "effectiveincometaxratereconciliationtaxcredits": 2.427,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 2.832,
    "effectiveincometaxratereconciliation162mlimitation": 0.012,
    "effectiveincometaxratereconciliationotheradjustments": 0.005,
    "effectiveincometaxratecontinuingoperations": 1.171,
    "deferredtaxassetsoperatinglosscarryforwards": 56767000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 22149000,
    "deferredtaxassetsleaseliability": 3501000,
    "deferredtaxassetsgoodwillandintangibleassets": 4400000,
    "deferredtaxassetsdeferredincome": 47286000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2425000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9600000,
    "deferredtaxassetsinprocessresearchanddevelopment": 32630000,
    "deferredtaxassetsother": 55000,
    "deferredtaxassetsgross": 178813000,
    "deferredtaxassetsvaluationallowance": 175454000,
    "deferredtaxassetsnet": 3359000,
    "deferredtaxliabilitiespropertyplantandequipment": 105000,
    "deferredtaxliabilitiesleasingarrangements": 3061000,
    "deferredtaxliabilitiesprepaidexpenses": 193000,
    "deferredincometaxliabilities": 3359000,
    "unrecognizedtaxbenefits": 19377000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 527000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": 9581000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 500000,
    "paymentsforrestructuring": 1457000,
    "changeofestimates": -55000
  },
  {
    "date": "2022-12-30",
    "symbol": "CTMX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CTMX",
    "entityregistrantname": "CytomX Therapeutics, Inc.",
    "entitycentralindexkey": 1501989,
    "currentfiscalyearenddate": "12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "true",
    "entityfilenumber": "001-37587",
    "entitytaxidentificationnumber": "27-3521219",
    "entityaddressaddressline1": "151 Oyster Point Boulevard,",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "515-3185",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.00001 par value",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "San Jose, California",
    "cashandcashequivalentsatcarryingvalue": 64706000,
    "accountsreceivablenetcurrent": 35986000,
    "prepaidexpenseandotherassetscurrent": 7466000,
    "assetscurrent": 237102000,
    "propertyplantandequipmentnet": 5072000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 875000,
    "goodwill": 949000,
    "restrictedcashnoncurrent": 900000,
    "operatingleaserightofuseasset": 15949000,
    "otherassetsnoncurrent": 27000,
    "assets": 260891000,
    "accountspayablecurrent": 2809000,
    "accruedliabilitiescurrent": 28532000,
    "contractwithcustomerliabilitycurrent": 121267000,
    "liabilitiescurrent": 152608000,
    "contractwithcustomerliabilitynoncurrent": 180059000,
    "operatingleaseliabilitynoncurrent": 13975000,
    "liabilities": 346642000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 637117000,
    "accumulatedothercomprehensiveincomelossnetoftax": 10000,
    "retainedearningsaccumulateddeficit": -722879000,
    "stockholdersequity": -722879000,
    "liabilitiesandstockholdersequity": 260891000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 53163000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseAndServiceMember",
    "researchanddevelopmentexpense": 111649000,
    "generalandadministrativeexpense": 42849000,
    "operatingexpenses": 154498000,
    "operatingincomeloss": -101335000,
    "investmentincomeinterest": 1678000,
    "othernonoperatingincomeexpense": 340000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -99317000,
    "netincomeloss": -99317000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 252000,
    "comprehensiveincomenetoftax": -99065000,
    "incomelossfromcontinuingoperationsperbasicshare": -1.51,
    "incomelossfromcontinuingoperationsperdilutedshare": -1.51,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesissued": "null",
    "stockissuedduringperiodsharesstockoptionsexercised": 102221,
    "stockissuedduringperiodvaluestockoptionsexercisedandrestrictedstockunitsreleased": 99000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexerciseofstockoptionsandreleaseofrestrictedstockunitsinperiod": 430096,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 549000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 405192,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13125000,
    "profitloss": -99317000,
    "amortizationofintangibleassets": 100000,
    "depreciationandamortizationexcludingamortizationofintangibleassets": 2297000,
    "gainlossonsalesofassetsandassetimpairmentcharges": -254000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 52000,
    "sharebasedcompensation": 13125000,
    "noncashleaseexpense": -3413000,
    "increasedecreaseinaccountsreceivable": 35196000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3181000,
    "increasedecreaseinotheroperatingassets": -874000,
    "increasedecreaseinaccountspayable": 68000,
    "increasedecreaseinaccruedliabilitiesincometaxpayableandotherliabilitiesnoncurrent": -9784000,
    "increasedecreaseincontractwithcustomerliability": 16565000,
    "netcashprovidedbyusedinoperatingactivities": -110788000,
    "paymentstoacquirepropertyplantandequipment": 1740000,
    "proceedsfromsalematurityandcollectionofshortterminvestments": 100000000,
    "netcashprovidedbyusedininvestingactivities": 98260000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 648000,
    "netcashprovidedbyusedinfinancingactivities": 648000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -11880000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 194567000,
    "capitalexpendituresincurredbutnotyetpaid": 6000,
    "numberofbusinessactivities": 1,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated life of the assets",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashcashequivalentsandshortterminvestments": 95574000,
    "cashcashequivalentsandshortterminvestmentsaccumulatedgrossunrealizedgainbeforetax": 10000,
    "restrictedcashandcashequivalentsatcarryingvalue": 917000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 29941000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 95564000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 10000,
    "availableforsalesecuritiesdebtsecurities": 29951000,
    "machineryandequipmentgross": 14002000,
    "computerequipmentandsoftwaregross": 1942000,
    "furnitureandfixturesgross": 1054000,
    "leaseholdimprovementsgross": 1742000,
    "constructioninprogressgross": 705000,
    "propertyplantandequipmentgross": 19445000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 14373000,
    "depreciation": 2300000,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": 12,
    "finitelivedintangibleassetsgross": 1750000,
    "finitelivedintangibleassetsaccumulatedamortization": 875000,
    "finitelivedintangibleassetsnet": 875000,
    "accruedresearchandclinicalcurrent": 13089000,
    "employeerelatedliabilitiescurrent": 8060000,
    "accruedprofessionalfeescurrent": 1413000,
    "operatingleaseliabilitycurrent": 4082000,
    "restructuringexpenses": 1627000,
    "otheraccruedliabilitiescurrent": 261000,
    "revenues": 53163000,
    "proceedsfromcollaborators": 30000000,
    "milestonepaymentreceived": 297000000,
    "aggregatecollaborationtransactionamount": 51700000,
    "estimatedresearchserviceperiod": "four years",
    "contractwithcustomerliability": 30000000,
    "contractwithcustomerassetnet": 1000000,
    "researchanddevelopmentarrangementcontracttoperformforothersdescriptionandterms": " Each collaboration target had a two-year research term and the two additional targets had to be nominated by Bristol Myers Squibb within five years of the effective date of the BMS Agreement. The research term for each collaboration target could be extended in one year increments up to three times.",
    "upfrontfeereceived": 30000000,
    "estimatedresearchfund": 21700000,
    "contractwithcustomerliabilityadditions": 69555000,
    "contractwithcustomerliabilityrevenuerecognized": 52989000,
    "deferredrevenuerecognitionmaturityyear": 2026,
    "royaltyobligationsfutureminimumpaymentsdue": 200000,
    "licenseterminationperiod": 60,
    "sublicensefees": 1000000,
    "losscontingencynameofplaintiff": "Vytacera Bio, LLC",
    "lesseeoperatingleasedescription": "The 2016 Lease has an initial term of ten years through 2026 and the Company has an option to extend the initial term for an additional five years at the then fair rental value as determined pursuant to the 2016 Lease.",
    "lettersofcreditoutstandingamount": 900000,
    "operatingleaseexpense": 5100000,
    "operatingleasepayments": 5273000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#LiabilitiesCurrent",
    "operatingleaseliability": 18057000,
    "operatingleaseweightedaverageremainingleaseterm1": 3.75,
    "operatingleaseweightedaveragediscountratepercent": 0.0825,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5420000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5572000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 5729000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4388000,
    "lesseeoperatingleaseliabilitypaymentsdue": 21109000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3052000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardvotingrightsofcommonstockholdingpercentage": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.77,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "allocatedsharebasedcompensationexpense": 13125000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 614000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "50% of the PSUs granted will occur within one year of the grant date upon achievement of certain specific milestones (\"2021-Tranche 1\") and the remaining 50% will vest within two years of the grant date upon achievement of additional company objectives (\"2021-Tranche 2\").",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 6.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 29300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 10300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 383750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 193750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 107500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 5.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.9329999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.961,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.047,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "valuationallowancedeferredtaxassetchangeinamount": 22700000,
    "operatinglosscarryforwards": 25700000,
    "operatinglosscarryforwardsexpirationyear": 2032,
    "operatinglosscarryforwardsamounttoexpireifnotused": 65599999.99999999,
    "operatinglosscarryforwardsamountnotsubjecttoexpiration": 203200000,
    "taxcreditcarryforwardamount": 13000000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.017,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.021,
    "effectiveincometaxratereconciliationtaxcredits": 0.024,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.228,
    "effectiveincometaxratereconciliation162mlimitation": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 58193000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 24700000,
    "deferredtaxassetsleaseliability": 3802000,
    "deferredtaxassetsgoodwillandintangibleassets": 3708000,
    "deferredtaxassetsdeferredincome": 49919000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1504000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8066000,
    "deferredtaxassetsinprocessresearchanddevelopment": 19709000,
    "deferredtaxassetsother": 31000,
    "deferredtaxassetsgross": 169632000,
    "deferredtaxassetsvaluationallowance": 166037000,
    "deferredtaxassetsnet": 3595000,
    "deferredtaxliabilitiespropertyplantandequipment": 43000,
    "deferredtaxliabilitiesleasingarrangements": 3358000,
    "deferredtaxliabilitiesprepaidexpenses": 194000,
    "deferredincometaxliabilities": 3595000,
    "unrecognizedtaxbenefits": 9269000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1391000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": 98000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 900000,
    "restructuringcosts": 7700000,
    "restructuringandrelatedcostexpectedcost1": 7970000,
    "paymentsforrestructuring": 5812000,
    "changeofestimates": -307000,
    "restructuringreservetranslationandotheradjustment": -175000,
    "restructuringreserve": 1676000
  },
  {
    "date": "2021-12-30",
    "symbol": "CTMX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CTMX",
    "entityregistrantname": "CytomX Therapeutics, Inc.",
    "entitycentralindexkey": 1501989,
    "currentfiscalyearenddate": "12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37587",
    "entitytaxidentificationnumber": "27-3521219",
    "entityaddressaddressline1": "151 Oyster Point Boulevard,",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "515-3185",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.00001 par value",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Redwood City, California",
    "cashandcashequivalentsatcarryingvalue": 165736000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 99696000,
    "accountsreceivablenetcurrent": 790000,
    "prepaidexpenseandotherassetscurrent": 4285000,
    "assetscurrent": 310301000,
    "propertyplantandequipmentnet": 5960000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 1021000,
    "goodwill": 949000,
    "restrictedcashnoncurrent": 900000,
    "operatingleaserightofuseasset": 19362000,
    "otherassetsnoncurrent": 901000,
    "assets": 339411000,
    "accountspayablecurrent": 2818000,
    "accruedliabilitiescurrent": 34236000,
    "contractwithcustomerliabilitycurrent": 69262000,
    "liabilitiescurrent": 106316000,
    "contractwithcustomerliabilitynoncurrent": 125660000,
    "operatingleaseliabilitynoncurrent": 18056000,
    "liabilities": 250032000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 623344000,
    "accumulatedothercomprehensiveincomelossnetoftax": -242000,
    "retainedearningsaccumulateddeficit": -533724000,
    "stockholdersequity": -533724000,
    "liabilitiesandstockholdersequity": 339411000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 69573000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseAndServiceMember",
    "researchanddevelopmentexpense": 114194000,
    "generalandadministrativeexpense": 39160000,
    "operatingexpenses": 153354000,
    "operatingincomeloss": -83781000,
    "investmentincomeinterest": 255000,
    "othernonoperatingincomeexpense": -83000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -83609000,
    "netincomeloss": -83609000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1.3,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -195000,
    "comprehensiveincomenetoftax": -83804000,
    "sharesissued": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 1428000,
    "stockissuedduringperiodsharesstockoptionsexercised": 528503,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1073000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 183865,
    "stockissuedduringperiodvaluenewissues": 107712000,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13167000,
    "profitloss": -83609000,
    "amortizationofintangibleassets": 100000,
    "depreciationandamortizationexcludingamortizationofintangibleassets": 2560000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -272000,
    "sharebasedcompensation": 13167000,
    "noncashleaseexpense": 3133000,
    "increasedecreaseinaccountsreceivable": -8000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2811000,
    "increasedecreaseinotheroperatingassets": -1271000,
    "increasedecreaseinaccountspayable": -139000,
    "increasedecreaseinaccruedliabilitiesincometaxpayableandotherliabilitiesnoncurrent": 7558000,
    "increasedecreaseincontractwithcustomerliability": -66209000,
    "netcashprovidedbyusedinoperatingactivities": -119031000,
    "paymentstoacquirepropertyplantandequipment": 1609000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 99898000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 123996000,
    "netcashprovidedbyusedininvestingactivities": 22489000,
    "proceedsfromissuanceofcommonstock": 107712000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 2501000,
    "netcashprovidedbyusedinfinancingactivities": 110213000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 13671000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 206447000,
    "capitalexpendituresincurredbutnotyetpaid": 83000,
    "numberofbusinessactivities": 1,
    "numberofoperatingsegments": 1,
    "operatingleaseliability": 21674000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated life of the assets",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "false",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashcashequivalentsandshortterminvestmentsamortizedcostbasis": 266591000,
    "cashcashequivalentsandshortterminvestmentsaccumulatedgrossunrealizedlossbeforetax": -242000,
    "cashcashequivalentsandshortterminvestments": 266349000,
    "restrictedcashandcashequivalentsatcarryingvalue": 917000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 99938000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 242000,
    "availableforsalesecuritiesdebtsecurities": 99696000,
    "debtsecuritiesavailableforsalematurityperiod": "twelve months",
    "machineryandequipmentgross": 15086000,
    "computerequipmentandsoftwaregross": 1608000,
    "furnitureandfixturesgross": 1054000,
    "leaseholdimprovementsgross": 1736000,
    "constructioninprogressgross": 308000,
    "propertyplantandequipmentgross": 19792000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 13832000,
    "depreciation": 2600000,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": 12,
    "finitelivedintangibleassetsgross": 1750000,
    "finitelivedintangibleassetsaccumulatedamortization": -729000,
    "finitelivedintangibleassetsnet": 1021000,
    "accruedresearchandclinicalcurrent": 18861000,
    "employeerelatedliabilitiescurrent": 9576000,
    "accruedprofessionalfeescurrent": 1468000,
    "operatingleaseliabilitycurrent": 3618000,
    "otheraccruedliabilitiescurrent": 713000,
    "revenues": 69573000,
    "milestonepaymentsreceivedfromrevenuerecognizedduringperiod": 100000000,
    "contractwithcustomerliability": 98800000,
    "contractwithcustomerassetnet": 800000,
    "researchanddevelopmentarrangementcontracttoperformforothersdescriptionandterms": "Each collaboration target had a two-year research term and the two additional targets had to be nominated by Bristol Myers Squibb within five years of the effective date of the BMS Agreement. The research term for each collaboration target could be extended in one year increments up to three times.",
    "contractwithcustomerliabilityrevenuerecognized": 66208000,
    "deferredrevenuerecognitionmaturityyear": 2025,
    "royaltyobligationsfutureminimumpaymentsdue": 200000,
    "licenseterminationperiod": 60,
    "sublicensefees": 1000000,
    "losscontingencynameofplaintiff": "Vytacera Bio, LLC",
    "lesseeoperatingleasedescription": "The 2016 Lease has an initial term of ten years through 2026 and the Company has an option to extend the initial term for an additional five years at the then fair rental value as determined pursuant to the 2016 Lease.",
    "lettersofcreditoutstandingamount": 900000,
    "operatingleaseexpense": 5100000,
    "operatingleasepayments": 5129000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LiabilitiesCurrent",
    "operatingleaseweightedaverageremainingleaseterm1": 4.75,
    "operatingleaseweightedaveragediscountratepercent": 0.0825,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5273000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5420000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 5572000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5729000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfiveandthereafter": 4387000,
    "lesseeoperatingleaseliabilitypaymentsdue": 26381000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4707000,
    "commonstockcapitalsharesreservedforfutureissuance": 486234,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardvotingrightsofcommonstockholdingpercentage": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "increaseincommonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.97,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 2100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "allocatedsharebasedcompensationexpense": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 874000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 3760000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "50% of the PSUs granted will vest within one year of the grant date upon achievement of certain specific milestones and the remaining 50% will vest within two years of the grant date upon achievement of additional company objectives.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 11.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1182000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1155000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 868250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 5750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 5.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.4687,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.6958,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "valuationallowancedeferredtaxassetchangeinamount": 18000,
    "operatinglosscarryforwards": 24200000,
    "operatinglosscarryforwardsexpirationyear": 2032,
    "operatinglosscarryforwardsamounttoexpireifnotused": 65599999.99999999,
    "operatinglosscarryforwardsamountnotsubjecttoexpiration": 160500000,
    "taxcreditcarryforwardamount": 11200000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "opentaxyear": "2010 2011 2012 2013 2014 2015 2016 2017 2018",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.021,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.043,
    "effectiveincometaxratereconciliationtaxcredits": 0.027999999999999997,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.21600000000000003,
    "deferredtaxassetsoperatinglosscarryforwards": 49186000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 20809000,
    "deferredtaxassetsleaseliability": 4555000,
    "deferredtaxassetsgoodwillandintangibleassets": 3804000,
    "deferredtaxassetsdeferredincome": 41291000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1933000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7480000,
    "deferredtaxassetsother": 29000,
    "deferredtaxassetsgross": 129087000,
    "deferredtaxassetsvaluationallowance": 124477000,
    "deferredtaxassetsnet": 4610000,
    "deferredtaxliabilitiespropertyplantandequipment": 253000,
    "deferredtaxliabilitiesleasingarrangements": 4069000,
    "deferredtaxliabilitiesprepaidexpenses": 288000,
    "deferredincometaxliabilities": 4610000,
    "unrecognizedtaxbenefits": 7780000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1326000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 900000
  },
  {
    "date": "2020-12-30",
    "symbol": "CTMX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CTMX",
    "entityregistrantname": "CytomX Therapeutics, Inc.",
    "entitycentralindexkey": 1501989,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Acceleratedfiler",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37587",
    "entitytaxidentificationnumber": "27-3521219",
    "entityaddressaddressline1": "151 Oyster Point Boulevard,",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "515-3185",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.00001 par value",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 131121000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 124260000,
    "accountsreceivablenetcurrent": 798000,
    "prepaidexpenseandotherassetscurrent": 7096000,
    "assetscurrent": 324013000,
    "propertyplantandequipmentnet": 6950000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 1167000,
    "goodwill": 949000,
    "restrictedcashnoncurrent": 900000,
    "operatingleaserightofuseasset": 22495000,
    "otherassetsnoncurrent": 2172000,
    "assets": 358663000,
    "accountspayablecurrent": 2996000,
    "accruedliabilitiescurrent": 23059000,
    "contractwithcustomerliabilitycurrent": 74869000,
    "liabilitiescurrent": 100924000,
    "contractwithcustomerliabilitynoncurrent": 186261000,
    "operatingleaseliabilitynoncurrent": 21675000,
    "liabilities": 308860000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 499964000,
    "accumulatedothercomprehensiveincomelossnetoftax": -47000,
    "retainedearningsaccumulateddeficit": -450115000,
    "stockholdersequity": -450115000,
    "liabilitiesandstockholdersequity": 358663000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 39600000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 112936000,
    "generalandadministrativeexpense": 36031000,
    "operatingexpenses": 148967000,
    "operatingincomeloss": -48605000,
    "investmentincomeinterest": 1836000,
    "othernonoperatingincomeexpense": -27000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -46796000,
    "incometaxexpensebenefit": -13911000,
    "netincomeloss": -32885000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -0.71,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -104000,
    "comprehensiveincomenetoftax": -32989000,
    "sharesissued": "null",
    "stockissuedduringperiodvaluenewissues": 11288000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 4876000,
    "stockissuedduringperiodsharesstockoptionsexercised": "null",
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 729000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 128684,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 14786000,
    "profitloss": -32885000,
    "amortizationofintangibleassets": 100000,
    "depreciationandamortizationexcludingamortizationofintangibleassets": 2427000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 236000,
    "sharebasedcompensation": 14786000,
    "noncashleaseexpense": 2887000,
    "increasedecreaseinaccountsreceivable": 785000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -81000,
    "increasedecreaseinotheroperatingassets": 157000,
    "increasedecreaseinaccountspayable": -857000,
    "increasedecreaseinaccruedliabilitiesincometaxpayableandotherliabilitiesnoncurrent": -11039000,
    "increasedecreaseincontractwithcustomerliability": 30891000,
    "netcashprovidedbyusedinoperatingactivities": 5259000,
    "paymentstoacquirepropertyplantandequipment": 2309000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 199108000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 182699000,
    "netcashprovidedbyusedininvestingactivities": -18718000,
    "proceedsfromissuanceofcommonstock": 11288000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 5605000,
    "netcashprovidedbyusedinfinancingactivities": 16893000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 3434000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 192776000,
    "capitalexpendituresincurredbutnotyetpaid": 122000,
    "numberofbusinessactivities": 1,
    "numberofoperatingsegments": 1,
    "operatingleaseliability": 24870000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated life of the assets",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "false",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "false",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashcashequivalentsandshortterminvestmentsamortizedcostbasis": 256292000,
    "cashcashequivalentsandshortterminvestmentsaccumulatedgrossunrealizedgainbeforetax": 6000,
    "cashcashequivalentsandshortterminvestments": 256298000,
    "restrictedcashandcashequivalentsatcarryingvalue": 917000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 124254000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 6000,
    "availableforsalesecuritiesdebtsecurities": 124260000,
    "machineryandequipmentgross": 13772000,
    "computerequipmentandsoftwaregross": 1600000,
    "furnitureandfixturesgross": 1024000,
    "leaseholdimprovementsgross": 1728000,
    "constructioninprogressgross": 252000,
    "propertyplantandequipmentgross": 18376000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 11426000,
    "depreciation": 2400000,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": 12,
    "finitelivedintangibleassetsgross": 1750000,
    "finitelivedintangibleassetsaccumulatedamortization": 583000,
    "finitelivedintangibleassetsnet": 1167000,
    "accruedresearchandclinicalcurrent": 10092000,
    "employeerelatedliabilitiescurrent": 8362000,
    "accruedprofessionalfeescurrent": 815000,
    "operatingleaseliabilitycurrent": 3195000,
    "otheraccruedliabilitiescurrent": 595000,
    "revenues": 100362000,
    "contractwithcustomerliability": 128300000.00000001,
    "contractwithcustomerassetnet": 800000,
    "researchanddevelopmentservicefees": 1500000,
    "researchanddevelopmentarrangementcontracttoperformforothersdescriptionandterms": "Each collaboration target had a two-year research term and the two additional targets had to be nominated by Bristol Myers Squibb within five years of the effective date of the BMS Agreement. The research term for each collaboration target could be extended in one year increments up to three times.",
    "contractwithcustomerliabilityadditions": 80000000,
    "contractwithcustomerliabilityrevenuerecognized": 89109000,
    "contractwithcustomerliabilitymaturitymonthandyear": "April 2025",
    "royaltyobligationsfutureminimumpaymentsdue": 200000,
    "licenseterminationperiod": 60,
    "sublicensefees": 9100000,
    "losscontingencynameofplaintiff": "Vytacera Bio, LLC",
    "lesseeoperatingleasedescription": "The term of the Lease commenced on October 1, 2016. The 2016 Lease has an initial term of ten years from the commencement date, and the Company has an option to extend the initial term for an additional five years at the then fair rental value as determined pursuant to the 2016 Lease. ",
    "lettersofcreditoutstandingamount": 900000,
    "operatingleaseexpense": 5100000,
    "operatingleasepayments": 4990000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y9M",
    "operatingleaseweightedaveragediscountratepercent": 0.0825,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5129000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5273000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 5420000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5572000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfiveandthereafter": 10116000,
    "lesseeoperatingleaseliabilitypaymentsdue": 31510000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 6640000,
    "percentageofsalescommissionandissuancecost": 0.03,
    "stockoptionsissuedandoutstanding": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforfutureissuanceunderemployeestockpurchaseplan": "null",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardvotingrightsofcommonstockholdingpercentage": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.94,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 23200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "allocatedsharebasedcompensationexpense": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantcancelledinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.58,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 13.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 10.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6844000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 6031000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 6844000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.473,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.221,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "valuationallowancedeferredtaxassetchangeinamount": -2700000,
    "unrecognizedtaxbenefits": 6500000,
    "operatinglosscarryforwards": 24200000,
    "operatinglosscarryforwardsexpirationyear": 2032,
    "operatinglosscarryforwardsamounttoexpireifnotused": 65599999.99999999,
    "operatinglosscarryforwardsamountnotsubjecttoexpiration": 103000000,
    "taxcreditcarryforwardamount": 9000000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "opentaxyear": "2010 2011 2012 2013 2014 2015 2016 2017 2018",
    "currentfederaltaxexpensebenefit": -13912000,
    "currentstateandlocaltaxexpensebenefit": 1000,
    "currentincometaxexpensebenefit": -13911000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.033,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.022000000000000002,
    "effectiveincometaxratereconciliationtaxcredits": 0.11,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.312,
    "effectiveincometaxratereconciliationnetoperatinglosscarryback": 0.27899999999999997,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratecontinuingoperations": 0.297,
    "deferredtaxassetsoperatinglosscarryforwards": 37099000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 16803000,
    "deferredtaxassetsleaseliability": 5223000,
    "deferredtaxassetsgoodwillandintangibleassets": 3923000,
    "deferredtaxassetsdeferredincome": 38832000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 1512000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8578000,
    "deferredtaxassetsother": 20000,
    "deferredtaxassetsgross": 111990000,
    "deferredtaxassetsvaluationallowance": 106448000,
    "deferredtaxassetsnet": 5542000,
    "deferredtaxliabilitiespropertyplantandequipment": 433000,
    "deferredtaxliabilitiesleasingarrangements": 4724000,
    "deferredtaxliabilitiesprepaidexpenses": 385000,
    "deferredincometaxliabilities": 5542000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1205000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 800000
  },
  {
    "date": "2019-12-30",
    "symbol": "CTMX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2019",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "CTMX",
    "entityregistrantname": "CytomX Therapeutics, Inc.",
    "entitycentralindexkey": 1501989,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-37587",
    "entitytaxidentificationnumber": "27-3521219",
    "entityaddressaddressline1": "151 Oyster Point Boulevard,",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "515-3185",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.00001 par value",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 188425000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 107720000,
    "accountsreceivablenetcurrent": 13000,
    "prepaidexpenseandotherassetscurrent": 7177000,
    "assetscurrent": 303335000,
    "propertyplantandequipmentnet": 7372000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 1312000,
    "goodwill": 949000,
    "restrictedcashnoncurrent": 900000,
    "operatingleaserightofuseasset": 25382000,
    "otherassetsnoncurrent": 2015000,
    "assets": 341282000,
    "accountspayablecurrent": 4158000,
    "accruedliabilitiescurrent": 200000,
    "contractwithcustomerliabilitycurrent": 51381000,
    "liabilitiescurrent": 85590000,
    "contractwithcustomerliabilitynoncurrent": 178858000,
    "operatingleaseliabilitynoncurrent": 24871000,
    "otherliabilitiesnoncurrent": 850000,
    "liabilities": 290169000,
    "commonstockvalue": 1000,
    "additionalpaidincapital": 468285000,
    "accumulatedothercomprehensiveincomelossnetoftax": 57000,
    "retainedearningsaccumulateddeficit": -417230000,
    "stockholdersequity": -417230000,
    "liabilitiesandstockholdersequity": 341282000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 17400000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 5000000,
    "generalandadministrativeexpense": 36765000,
    "operatingexpenses": 168384000,
    "operatingincomeloss": -110895000,
    "investmentincomeinterest": 8365000,
    "othernonoperatingincomeexpense": -135000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -102665000,
    "incometaxexpensebenefit": -427000,
    "netincomeloss": -102238000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -2.26,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 139000,
    "taxcutsandjobsactof2017reclassificationfromaocitoretainedearningstaxeffect": 11000,
    "comprehensiveincomenetoftax": -102088000,
    "sharesissued": "null",
    "cumulativeeffectonretainedearningsnetoftax1": 11000,
    "stockissuedduringperiodvaluenewissues": 1602000,
    "stockissuedduringperiodsharesnewissues": 150000,
    "stockissuedduringperiodvaluestockoptionsexercised": 633000,
    "stockissuedduringperiodsharesstockoptionsexercised": 146930,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 994000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 142949,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 19100000,
    "profitloss": -102238000,
    "amortizationofintangibleassets": 100000,
    "depreciationandamortizationexcludingamortizationofintangibleassets": 2459000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2228000,
    "sharebasedcompensation": 19100000,
    "issuanceofstockandwarrantsforservicesorclaims": 1602000,
    "increasedecreaseinaccountsreceivable": -84000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2074000,
    "increasedecreaseinotheroperatingassets": 640000,
    "increasedecreaseinaccountspayable": -374000,
    "increasedecreaseinaccruedliabilitiesincometaxpayableandotherliabilitiesnoncurrent": -12724000,
    "increasedecreaseincontractwithcustomerliability": -47741000,
    "netcashprovidedbyusedinoperatingactivities": -140480000,
    "paymentstoacquirepropertyplantandequipment": 3497000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 174992000,
    "proceedsfromsaleofavailableforsalesecuritiesdebt": 258190000,
    "netcashprovidedbyusedininvestingactivities": 79701000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 1627000,
    "netcashprovidedbyusedinfinancingactivities": 1627000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -59152000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 189342000,
    "incometaxespaid": 13061000,
    "capitalexpendituresincurredbutnotyetpaid": 428000,
    "numberofbusinessactivities": 1,
    "numberofoperatingsegments": 1,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 189342000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of remaining lease term or estimated life of the assets",
    "operatingleaseliability": 27681000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "availableforsalesecuritiesamortizedcost": 279284000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 110000,
    "availableforsalesecurities": 279394000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 107610000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 110000,
    "availableforsalesecuritiesdebtsecurities": 107720000,
    "machineryandequipmentgross": 12124000,
    "computerequipmentandsoftwaregross": 1555000,
    "furnitureandfixturesgross": 1024000,
    "leaseholdimprovementsgross": 1483000,
    "constructioninprogressgross": 236000,
    "propertyplantandequipmentgross": 16422000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 9050000,
    "depreciation": 2500000,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": 12,
    "finitelivedintangibleassetsgross": 1750000,
    "finitelivedintangibleassetsaccumulatedamortization": 438000,
    "finitelivedintangibleassetsnet": 1312000,
    "accruedresearchandclinicalcurrent": 19006000,
    "employeerelatedliabilitiescurrent": 6721000,
    "accruedprofessionalfeescurrent": 1062000,
    "operatingleaseliabilitycurrent": 2810000,
    "otheraccruedliabilitiescurrent": 452000,
    "revenues": 57489000,
    "aggregatecollaborationtransactionamount": 4800000,
    "revenueremainingperformanceobligation": 4800000,
    "estimatedresearchserviceperiod": "six years",
    "contractwithcustomerliability": 158000000,
    "contractwithcustomerassetnet": 13000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "five years",
    "researchanddevelopmentarrangementcontracttoperformforothersdescriptionandterms": "Each collaboration target had a two-year research term and the two additional targets had to be nominated by Bristol-Myers Squibb within ",
    "estimatedresearchserviceterminationdate": "April 25, 2025",
    "contractwithcustomerliabilityadditions": 10000000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 10000000,
    "contractwithcustomerliabilityrevenuerecognized": 57741000,
    "contractwithcustomerliabilitymaturitymonthandyear": "April 2025",
    "royaltyobligationsfutureminimumpaymentsdue": 150000,
    "licenseterminationperiod": 60,
    "sublicensefees": 4300000,
    "upfrontlicensepayment": 7500000,
    "lesseeoperatingleasedescription": "The term of the Lease commenced on October 1, 2016. The 2016 Lease has an initial term of ten years from the commencement date, and the Company has an option to extend the initial term for an additional five years at the then fair rental value as determined pursuant to the 2016 Lease. ",
    "lesseeoperatingleasetermofcontract": "ten years",
    "lesseeoperatingleaserenewalterm": "five years",
    "lettersofcreditoutstandingamount": 900000,
    "operatingleaseexpense": 4800000,
    "operatingleasepayments": 4855000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesCurrent",
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y10M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.0825,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4990000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5129000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 5273000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5420000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfiveandthereafter": 15689000,
    "lesseeoperatingleaseliabilitypaymentsdue": 36501000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 8820000,
    "stockoptionsissuedandoutstanding": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforfutureissuanceunderemployeestockpurchaseplan": "null",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardvotingrightsofcommonstockholdingpercentage": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.03,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 31100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "allocatedsharebasedcompensationexpense": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantforfeituresinperiod": 912127,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 990358,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 12.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 16.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 12.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 14220000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 13310000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 14220000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.6081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.7189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0162,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0235,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "currentfederaltaxexpensebenefit": -390000,
    "currentincometaxexpensebenefit": -390000,
    "deferredfederalincometaxexpensebenefit": -37000,
    "deferredincometaxexpensebenefit": -37000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.013000000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.012,
    "effectiveincometaxratereconciliationtaxcredits": 0.025,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.228,
    "effectiveincometaxratereconciliationreturntoprovisionadjustments": 0.003,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratecontinuingoperations": 0.004,
    "deferredtaxassetsoperatinglosscarryforwards": 38967000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10940000,
    "deferredtaxassetsleaseliability": 5813000,
    "deferredtaxassetsgoodwillandintangibleassets": 3320000,
    "deferredtaxassetsdeferredincome": 47180000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 1296000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7837000,
    "deferredtaxassetsgross": 115353000,
    "deferredtaxassetsvaluationallowance": 109174000,
    "deferredtaxassetsnet": 6179000,
    "deferredtaxliabilitiespropertyplantandequipment": 591000,
    "deferredtaxliabilitiesrightofuseassets": 5330000,
    "deferredtaxliabilitiesprepaidexpenses": 243000,
    "deferredtaxliabilitiesother": 15000,
    "deferredincometaxliabilities": 6179000,
    "valuationallowancedeferredtaxassetchangeinamount": 22700000,
    "operatinglosscarryforwards": 24200000,
    "operatinglosscarryforwardsexpirationyear": 2032,
    "operatinglosscarryforwardsamounttoexpireifnotused": 65599999.99999999,
    "operatinglosscarryforwardsamountnotsubjecttoexpiration": 111900000,
    "taxcreditcarryforwardamount": 7100000,
    "taxcreditcarryforwardexpirationyear": 2031,
    "unrecognizedtaxbenefits": 5200000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 900000,
    "opentaxyear": "2010 2011 2012 2013 2014 2015 2016 2017 2018",
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1403000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": 90000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 800000
  }
]